TELMIVIB CC 6.25TELMISARTAN 40mg. IP + CHLORTHALIDONE 6.25mg. IP + CILNIDIPINE 10mg. IP

Telmivib CC 6.25 tablets combine telmisartan 40 mg, chlorthalidone 6.25 mg and cilnidipine 10 mg for high blood pressure. Main uses: treatment of hypertension (high blood pressure) to lower blood pressure; lowering blood pressure to reduce the risk of heart and blood vessel events such as stroke and heart attack; useful when blood pressure is not controlled by a single medicine, as the three ingredients act in different ways.

Common side effects of Telmivib CC 6.25 Tablet include dizziness or light-headedness; headache; back pain; nausea, stomach upset or diarrhoea; sinusitis; weakness or tiredness. Get medical help at once if you notice marked fall in blood pressure (symptomatic hypotension), especially in volume- or salt-depleted patients; swelling of the face, lips or tongue (angioedema); kidney problems or changes in kidney function.

Each Telmivib CC 6.25 tablet contains Telmisartan 40 mg + Chlorthalidone 6.25 mg + Cilnidipine 10 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Telmivib CC 6.25 Tablet only as your doctor advises.

The MRP of Telmivib CC 6.25 Tablet is ₹139 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹105.9 and the PTS is ₹95.31.

Each Telmivib CC 6.25 tablet contains Telmisartan 40 mg + Chlorthalidone 6.25 mg + Cilnidipine 10 mg. It comes in a pack of 10x10 (Alu Alu).

Three ingredients act in different ways on blood pressure. Telmisartan blocks angiotensin II at its receptor so blood vessels relax. Chlorthalidone works on the kidneys to remove extra salt and water, which lowers blood volume. Cilnidipine limits calcium entry into vessel walls so they widen. Together they reduce the force of blood against artery walls.

Must not be used in pregnancy; if pregnancy is detected, stop the medicine immediately as it can injure the developing baby. Must not be used by patients allergic to telmisartan, chlorthalidone, cilnidipine or sulfonamide-derived drugs. Must not be used in anuria (no urine production). Must not be taken with aliskiren in patients with diabetes. Concomitant use with an ACE inhibitor must be avoided; volume or salt depletion must be corrected before treatment is started, and a doctor should be consulted first in severe kidney or liver disease.

Telmivib CC 6.25 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.